Issue 5/2020
Content (8 Articles)
Naltrexone
Leading Article
Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?
E. Andrew Townsend, Matthew L. Banks
Migraine
Systematic Review
Safety and Efficacy of Ubrogepant for the Acute Treatment of Episodic Migraine: A Meta-Analysis of Randomized Clinical Trials
Yanbo Yang, Mingjia Chen, Yue Sun, Bixi Gao, Zhouqing Chen, Zhong Wang
Schizophrenia
Review Article
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
Nicholas Keks, Judith Hope, Darren Schwartz, Harold McLennan, David Copolov, Graham Meadows
Antidepressant Drugs
Review Article
The Efficacy and Safety of Concomitant Psychotropic Medication and Electroconvulsive Therapy (ECT)
A. Umair Janjua, Amitha L. Dhingra, Robert Greenberg, William M. McDonald
Original Research Article
Predicted Cellular and Molecular Actions of Lithium in the Treatment of Bipolar Disorder: An In Silico Study
Hadi Najafi, Mehdi Totonchi, Majid Sadeghizadeh
Multiple Sclerosis
Original Research Article
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab
Eleonora Sgarlata, Clara Grazia Chisari, Emanuele D’Amico, Enrico Millefiorini, Francesco Patti
Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring
Anemone von Blomberg, Lara Kay, Susanne Knake, Sven Fuest, Johann Philipp Zöllner, Philipp S. Reif, Eva Herrmann, Ümniye Balaban, Susanne Schubert-Bast, Felix Rosenow, Adam Strzelczyk
Status Epilepticus
Commentary
Transnasal Revolution? The Promise of Midazolam Spray to Prevent Seizure Clusters
Raoul Sutter, Peter W. Kaplan